Patent Assignment
Reel/Frame 036315/0188
Security Interest
Recorded: 2015-08-10
Pages: 37
Assignor
DECIPHERA PHARMACEUTICALS, LLC
Executed: 2015-05-01
Assignee
BRIGHTSTAR ASSOCIATES LLC
8433 QUIVIRA BOULEVARD, LENEXA, KANSAS, 60215
Covered Properties
(30)
Anti-Cancer Medicaments
Anti-Inflammatory Medicaments
Anti-Inflammatory Medicaments
Dihydropyridopyrimidinyl, Dihydronaphthyridinyl, and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and Other Proliferative Diseases
Enzyme Modulators and Treatments
Kinase Inhibitors Useful for the Treatment of Myleoprolific Diseases and Other Proliferative Diseases
N-Acyl Ureas Exhibiting Anti-Cancer and Anti-Proliferative Activities
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and Other Proliferative Diseases
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Patent:
8,461,179 →
Application:
13/491,394 →
Cyclopropyl Dicarboxamides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Cyclopropane Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Raf Inhibitor Compounds
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Imidazolidinones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
1,2,4-Triazol-5-Ones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
2-Aminopyrimidin-6-Ones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
N-Acyl-N'-(Pyridin-2-Yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Raf Inhibitor Compounds
Raf Inhibitor Compounds
Methods for Inhibiting Tie-2 Kinase Useful in the Treatment of Cancer
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Application:
14/560,809 →
Publication:
US 2015/0320759
Cyclopropyl Dicarboxamides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Application:
14/602,781 →
Publication:
US 2015/0218130
Iinhibition of Tumor Cell Interactions with the Microenvironment Resulting in a Reduction in Tumor Growth and Disease Progression
Application:
62/063,656 →
Inhibition of Trk Kinase Mediated Tumor Growth and Disease Progression
Application:
62/063,660 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jul 5, 2012
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 028503/0011 →
Assignment of Assignor's Interest
Jul 9, 2013
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.; PETILLO, PETER A.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 030760/0705 →
Assignment of Assignor's Interest
Oct 6, 2014
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 033895/0551 →
Assignment of Assignor's Interest
Feb 5, 2015
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 034894/0499 →
Security Interest
Aug 10, 2015
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 036288/0037 →
Security Interest
Aug 10, 2015
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 036315/0091 →
Release of Security Interest
Dec 24, 2015
From: BRIGHTSTAR ASSOCIATES, LLC
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 037359/0831 →
Release of Security Interest
Dec 24, 2015
From: BRIGHTSTAR ASSOCIATES, LLC
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 037359/0866 →